We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

ALCOR Scientific Inc.

  Gold ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Alcor Scientific Partners with Health Care Investor Water Street to Accelerate Expansion

By LabMedica International staff writers
Posted on 01 Mar 2022
Print article
Image: Alcor Scientific Partners with Water Street (Photo courtesy of Unsplash)
Image: Alcor Scientific Partners with Water Street (Photo courtesy of Unsplash)

Alcor Scientific (Smithfield, RI, USA) has partnered with strategic health care investor Water Street Healthcare Partners (Chicago, IL, USA) which has committed significant capital to invest in Alcor's expansion.

Alcor plans to leverage Water Street's investment to achieve its goals for accelerating the development of new technologies, expanding its product portfolio and bolstering its global reach. Alcor is one of the only providers to offer a fully automated solution for Erythrocyte Sedimentation Rate (ESR) testing, which measures inflammation for a range of clinical purposes, including diagnosing and monitoring autoimmune diseases, cancer and infections. More than 1,100 hospitals and reference laboratories around the world have adopted Alcor's proprietary testing system comprised of analyzers and consumable tests. Water Street has committed significant capital to invest in Alcor's research and development initiatives, product portfolio and international expansion.

"Innovation is the cornerstone of Alcor," said Carlo Ruggeri, founder of Alcor. "Our family founded and grew this company by conceiving and developing new medical technologies that meaningfully improve patient care. I'm very pleased to have found in Water Street a strategic partner that values our legacy and will help us build on it. Water Street's diagnostics and medical products expertise combined with the experience of our new CEO, Jim Post, will help us not only build - but accelerate - Alcor's next phase of innovation and growth."

"Alcor stands out for its exceptionally high customer satisfaction and retention ratings," added Scott Garrett, operating partner at Water Street. "Health care providers greatly value Alcor's ESR testing system, saying it helps save time and labor costs to improve their overall workflow. Together with Carlo and the leadership team, we will build on this strong foundation through organic investments and acquisitions of complementary products and technologies to extend its product portfolio and global reach."

"Alcor is an outstanding company with great people who are passionate about what they do and it shows in their results," said Jim Post, Alcor’s newly-appointed CEO. "I'm excited to be joining the company at this point in its history and development and to work together to achieve our shared goal of building Alcor into a global diagnostics leader."

Related Links:
Alcor Scientific
Water Street Healthcare Partners 

Gold Supplier
SARS-CoV-2 Antigen Test
NG-Test SARS-NG-Test SARS-CoV-2 Ag Cassette
New
Silver Supplier
Receptor Destroying Enzyme
RDE II (Receptor Destroying Enzyme)
New
Automated R-AST Solution
Radian BC
New
Benchtop Centrifuge & Vortexer
ExiSpin

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.